The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Double genetic disruption of lactate dehydrogenases A and B is required to ablate the “Warburg effect” restricting tumor growth to oxidative metabolism
Open accessAbstract
Increased glucose consumption distinguishes cancer cells from normal cells and is known as the "Warburg effect" because of increased glycolysis. Lactate dehydrogenase A (LDHA) is a key glycolytic enzyme, a hallmark of aggressive cancers, and believed to be the major enzyme responsible for pyruvate-to-lactate conversion. To elucidate its role in tumor growth, we disrupted both the LDHA and LDHB genes in two cancer cell lines (human colon adenocarcinoma and murine melanoma cells). Surprisingly, neither LDHA nor LDHB knockout strongly reduced lactate secretion. In contrast, double knockout ( LDHA/B -DKO) fully suppressed LDH activity and lactate secretion. Furthermore, under normoxia, LDHA/B -DKO cells survived the genetic block by shifting their metabolism to oxidative phosphorylation (OXPHOS), entailing a 2-fold reduction in proliferation rates in vitro and in vivo compared with their WT counterparts. Under hypoxia (1% oxygen), however, LDHA/B suppression completely abolished in vitro growth, consistent with the reliance on OXPHOS. Interestingly, activation of the respiratory capacity operated by the LDHA/B -DKO genetic block as well as the resilient growth were not consequences of long-term adaptation. They could be reproduced pharmacologically by treating WT cells with an LDHA/B-specific inhibitor (GNE-140). These findings demonstrate that the Warburg effect is not only based on high LDHA expression, as both LDHA and LDHB need to be deleted to suppress fermentative glycolysis. Finally, we demonstrate that the Warburg effect is dispensable even in aggressive tumors and that the metabolic shift to OXPHOS caused by LDHA / B genetic disruptions is responsible for the tumors' escape and growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046 · cited 1×
“Last but not least, lactic acid is involved in tumor immune response (39, 40).”
BackgroundTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Understanding the Intersections between Metabolism and Cancer Biology
Vander Heiden, M. G., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,293
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Brand, A., Singer, K., Koehl, G. E., Kolitzus, M., Schoenhammer, G., Thiel, A., Matos, C., Bruss, C., Klobuch, S., Peter, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.011 · Cited by 2,039
Self-citationInhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
Self-citationSerine, glycine and one-carbon units: cancer metabolism in full circle
Locasale, J. W. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3557 · Cited by 1,673
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635 · cited 1×
“(14), who had already shown earlier that LDHA silencing reduced LDHA activity, stimulated respiration in vitro, and reduced the tumorigenicity of murine breast cancer cells in a syngeneic immunocompetent in vivo model.”
BackgroundInhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Vander Jagt, D. L., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,516
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Hay, N. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.77 · Cited by 1,115
Lactate: A Metabolic Key Player in Cancer
Hirschhaeuser, F., Sattler, U. G. A., & Mueller-Klieser, W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1457 · Cited by 1,090
MULTIPLE FORMS OF ENZYMES: TISSUE, ONTOGENETIC, AND SPECIES SPECIFIC PATTERNS
Markert, C. L., & Møller, F. (1959) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.45.5.753 · Cited by 1,072
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
Cascone, T., McKenzie, J. A., Mbofung, R. M., Punt, S., Wang, Z., Xu, C., Williams, L. J., Wang, Z., Bristow, C. A., Carugo, A., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.024 · Cited by 611
Disrupting proton dynamics and energy metabolism for cancer therapy
Parks, S. K., Chiche, J., & Pouysségur, J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3579 · Cited by 607
Self-citationXie, H., Hanai, J.-I., Ren, J.-G., Kats, L., Burgess, K., Bhargava, P., Signoretti, S., Billiard, J., Duffy, K. J., Grant, A., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.003 · Cited by 516
Semenza, G. L. (2017) · The EMBO Journal · doi:10.15252/embj.201695204 · Cited by 366
MYC and metabolism on the path to cancer
Hsieh, A. L., Walton, Z. E., Altman, B. J., Stine, Z. E., & Dang, C. V. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.08.003 · Cited by 332
Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters
Marchiq, I., & Pouysségur, J. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1307-x · Cited by 300
Self-citationRegulation of cell proliferation by hypoxia-inducible factors
Hubbi, M. E., & Semenza, G. L. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00279.2015 · Cited by 300
Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition
Boudreau, A., Purkey, H. E., Hitz, A., Robarge, K., Peterson, D., Labadie, S., Kwong, M., Hong, R., Gao, M., Del Nagro, C., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2143 · Cited by 280
Self-citationIsoCor: correcting MS data in isotope labeling experiments
Millard, P., Letisse, F., Sokol, S., & Portais, J.-C. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts127 · Cited by 278
Sheng, S. L., Liu, J. J., Dai, Y. H., Sun, X. G., Xiong, X. P., & Huang, G. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08748.x · Cited by 263
Free radical scavenging and antioxidant effects of lactate ion: an in vitro study
Groussard, C., Morel, I., Chevanne, M., Monnier, M., Cillard, J., & Delamarche, A. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.1.169 · Cited by 242
Pouysségur, J., Chambard, J. C., Franchi, A., Paris, S., & Van Obberghen-Schilling, E. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.13.3935 · Cited by 241
Self-citationLactate dehydrogenase 5: An old friend and a new hope in the war on cancer
Augoff, K., Hryniewicz-Jankowska, A., & Tabola, R. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.12.035 · Cited by 241
Polet, F., & Feron, O. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12016 · Cited by 232
Hypoxia and acidosis: immune suppressors and therapeutic targets
Damgaci, S., Ibrahim‐Hashim, A., Enriquez‐Navas, P. M., Pilon‐Thomas, S., Guvenis, A., & Gillies, R. J. (2018) · Immunology · doi:10.1111/imm.12917 · Cited by 231
Hypoxia and energetic tumour metabolism
Brahimi-Horn, M. C., Bellot, G., & Pouysségur, J. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.006 · Cited by 226
Self-citationMitochondrial Akt Regulation of Hypoxic Tumor Reprogramming
Chae, Y. C., Vaira, V., Caino, M. C., Tang, H.-Y., Seo, J. H., Kossenkov, A. V., Ottobrini, L., Martelli, C., Lucignani, G., Bertolini, I., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.004 · Cited by 209
The Use of Variable Q1 Isolation Windows Improves Selectivity in LC–SWATH–MS Acquisition
Zhang, Y., Bilbao, A., Bruderer, T., Luban, J., Strambio-De-Castillia, C., Lisacek, F., Hopfgartner, G., & Varesio, E. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00543 · Cited by 193
An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast Cancer
McCleland, M. L., Adler, A. S., Shang, Y., Hunsaker, T., Truong, T., Peterson, D., Torres, E., Li, L., Haley, B., Stephan, J.-P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1098 · Cited by 191
Self-citationMarchiq, I., Le Floch, R., Roux, D., Simon, M.-P., & Pouyssegur, J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2260 · Cited by 175
Wang, Z.-Y., Loo, T. Y., Shen, J.-G., Wang, N., Wang, D.-M., Yang, D.-P., Mo, S.-L., Guan, X.-Y., & Chen, J.-P. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1466-6 · Cited by 169
Hypoxia and cellular metabolism in tumour pathophysiology
Parks, S. K., Cormerais, Y., & Pouysségur, J. (2017) · The Journal of Physiology · doi:10.1113/jp273309 · Cited by 152
Self-citationLactate Dehydrogenase B Is Required for the Growth of KRAS-Dependent Lung Adenocarcinomas
McCleland, M. L., Adler, A. S., Deming, L., Cosino, E., Lee, L. B., Blackwood, E. M., Solon, M., Tao, J., Li, L., Shames, D. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2638 · Cited by 149
Vučetić, M., Cormerais, Y., Parks, S. K., & Pouysségur, J. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00319 · Cited by 129
Self-citationRegulation of mTORC1 Signaling by pH
Balgi, A. D., Diering, G. H., Donohue, E., Lam, K., Fonseca, B. D., Zimmerman, C., Numata, M., & Roberge, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021549 · Cited by 121
Pouysségur, J., Franchi, A. J., Salomon, J.-C., & Silvestre, P. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2698 · Cited by 112
Self-citationMeasurement of total lactate dehydrogenase activity.
VANDERLINDE, R. E. (1985) · PubMed · Cited by 105
Small-Molecule Inhibitors of Human Ldh5
Granchi, C., Paterni, I., Rani, R., & Minutolo, F. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.151 · Cited by 99
de Padua, M. M. C., Delodi, G., Vučetić, M., Durivault, J., Vial, V., Bayer, P., Noleto, G. R., Mazure, N. M., Ždralević, M., & Pouysségur, J. (2017) · Oncotarget · doi:10.18632/oncotarget.21007 · Cited by 92
Self-citationImmunochemical Specificity of Lactate Dehydrogenase-X
Goldberg, E. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.2.349 · Cited by 87
Lactate Dehydrogenase Isozymes: Substrate Inhibition in Various Human Tissues
Vesell, E. S. (1965) · Science · doi:10.1126/science.150.3703.1590 · Cited by 70
Hypoxia promotes tumor cell survival in acidic conditions by preserving ATP levels
Parks, S. K., Mazure, N. M., Counillon, L., & Pouysségur, J. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24346 · Cited by 68
Self-citationFeist, M., Schwarzfischer, P., Heinrich, P., Sun, X., Kemper, J., von Bonin, F., Pérez-Rubio, P., Taruttis, F., Rehberg, T., Dettmer, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03803-x · Cited by 59
Self-citationPouysségur, J., Franchi, A. J., & Silvestre, P. (1980) · Nature · doi:10.1038/287445a0 · Cited by 47
Self-citationSun, W., Zhang, X., Ding, X., Li, H., Geng, M., Xie, Z., Wu, H., & Huang, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125976 · Cited by 46
Metabolic Reprogramming and Oncogenesis
Costa, A. S. H., & Frezza, C. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.01.001 · Cited by 32
Lactate dehydrogenase isozymes: Qualitative and quantitative changes during primate evolution
Koen, A. L., & Goodman, M. (1969) · Biochemical Genetics · doi:10.1007/bf00485606 · Cited by 22
The tumour microenvironment: causes and consequences of hypoxia and acidity. Introduction.
Gillies, R. J. (2001) · PubMed · Cited by 15
Gillies, R. J. (2001) · Novartis Foundation symposium · doi:10.1002/0470868716.ch1 · Cited by 10
Cited by
Targeting cancer metabolism in the era of precision oncology
Stine, Z. E., Schug, Z. T., Salvino, J. M., & Dang, C. V. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00339-6 · Cited by 1,189
Mitochondrial Metabolism as a Target for Cancer Therapy
Vasan, K., Werner, M., & Chandel, N. S. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.019 · Cited by 736
Lactate in the tumour microenvironment: From immune modulation to therapy
Wang, Z.-H., Peng, W.-B., Zhang, P., Yang, X.-P., & Zhou, Q. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103627 · Cited by 528
Mitochondrial DNA copy number in human disease: the more the better?
Filograna, R., Mennuni, M., Alsina, D., & Larsson, N. (2021) · FEBS Letters · doi:10.1002/1873-3468.14021 · Cited by 478
LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis
Arra, M., Swarnkar, G., Ke, K., Otero, J. E., Ying, J., Duan, X., Maruyama, T., Rai, M. F., O’Keefe, R. J., Mbalaviele, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17242-0 · Cited by 412
Metadata
- Authors
- Ždralević, M., Brand, A., Di Ianni, L., Dettmer, K., Reinders, J., Singer, K., Peter, K., Schnell, A., Bruss, C., Decking, S.-M., Koehl, G., Felipe-Abrio, B., Durivault, J., Bayer, P., Evangelista, M., O'Brien, T., Oefner, P. J., Renner, K., Pouysségur, J., & Kreutz, M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 293
- Issue
- 41
- Pages
- 15947-15961
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2889229834
- Cited by
- 255
- References
- 57
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.